Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Abstract

OBJECTIVES To evaluate the clinical effectiveness, safety, tolerability and cost-effectiveness of etanercept and infliximab for the treatment of active and progressive psoriatic arthritis (PsA) in patients who have inadequate response to standard treatment, including disease-modifying antirheumatic drug (DMARD) therapy. DATA SOURCES Electronic databases… (More)

37 Figures and Tables

Topics

  • Presentations referencing similar topics